ALL-HEART: No benefit of allopurinol in ischemic heart disease
Allopurinol, a drug commonly used to treat gout, provided no benefit in reducing cardiovascular (CV) events in patients with ischemic heart disease, new randomized trial results show. Treatment of these non-gout patients with allopurinol 600 mg daily had no effect on composite primary outcomes, including nonfatal myocardial infarction (MI), nonfatal stroke, or CV death . …
ALL-HEART: No benefit of allopurinol in ischemic heart disease Read More »